Law report No. GLW-1877 · filed November 17, 2026
LegislationReported case
India’s biodiversity law weakens Northeast oral knowledge safeguards
India’s 2023 biodiversity amendment exempts codified traditional knowledge from benefit sharing, but oral remedies in the Northeast remain inside a weakened regime with little defensive protection.
By Amara Osei4 min read873 words
Holding
- Section 2(ea) of the 2023 Act defines codified traditional knowledge through listed classical texts.
- The Uttarakhand High Court decided Divya Pharmacy v. Union of India on 21 December 2018.
- The 2025 regulations tie access-and-benefit-sharing fees to turnover.
- A People’s Biodiversity Register does not convert oral knowledge into Section 2(ea) codified knowledge.
- The Traditional Knowledge Digital Library covers five codified traditions.

Amara Osei
On 21 December 2018, the High Court of Uttarakhand held in Divya Pharmacy v. Union of India, Writ Petition (M/S) No. 3437 of 2016, that biological resources “are the property of the nation” and that an Indian company must share benefits with local and indigenous communities when using their resources or knowledge.
Divya Pharmacy, an Ayurvedic manufacturer with no foreign shareholding, had to pay. The ruling protected community rights against domestic appropriation, not merely foreign exploitation. Parliament later moved the statutory line.
What did the 2023 amendment change?
The Biological Diversity (Amendment) Act, 2023 (No. 10 of 2023) modernised a law then two decades old and promised lighter compliance for the traditional-medicine industry. The Lok Sabha passed the amendment bill in 2021. Sponsors cited lower burdens and the need to attract investment.
Section 2(ea) defines “codified traditional knowledge” as knowledge derived from the authoritative books listed in the First Schedule to the Drugs and Cosmetics Act, 1940: the classical texts of Ayurveda, Siddha and Unani.
The Act removes codified knowledge from access-and-benefit-sharing obligations. It also exempts practitioners of AYUSH systems dealing in cultivated medicinal plants and drops codified-knowledge holders from the definition of “benefit claimers”. The classical text becomes a freely usable national resource, and its commercial users owe no benefit share.
The underlying analysis links the change to Divya Pharmacy. It says industry resistance to the 2018 ruling contributed to an amendment that exempted the category the court had held liable.
Takeaway: Codified traditions gained freedom from benefit sharing; uncodified knowledge did not.
Why does documentation matter in the Northeast?
Communities across Northeast India hold a vast, largely unwritten pharmacopoeia built over generations. The region includes the Indo-Burma biodiversity hotspot, one of the world’s richest concentrations of plant life. The amendment distinguishes the medium of transmission, not the value of the knowledge.
- A Khasi healer’s use of a forest herb and a Mishmi household’s fever remedy never entered the recognised classical texts. Neither did the cultivation knowledge behind the Naga chilli.
- Coptis teeta, or Mishmi teeta, is an endemic, threatened eastern-Himalayan herb that Mishmi and neighbouring tribes in Arunachal Pradesh use against malaria, dysentery and stomach ailments. Its active compound, berberine, has pharmaceutical interest.
- Bhut Jolokia, or Naga chilli, has been grown for generations across Assam, Nagaland and Manipur. It carries a geographical-indication tag, and the Defence Research and Development Organisation extracts its oleoresin for riot-control munitions.
Because this knowledge is uncodified, it remains inside the benefit-sharing regime and its communities retain formal claimant status. The paperwork decides the economics.
Takeaway: A remedy’s age and importance cannot compensate for its absence from classical texts.
How did the amendment weaken the remaining regime?
The 2023 amendment also decriminalised offences under the Act. Government-appointed adjudicating officers now impose penalties where courts previously did.
The National Biodiversity Authority’s patent-approval requirement moved from before an application to before a grant. That change narrows the window in which misuse can be caught.
Regulations notified in 2025 tie the access-and-benefit-sharing fee to turnover. Critics read the measure as centralising control and reducing communities’ influence over sharing terms. The underlying analysis calls this a hollowed-out regime: communities keep formal rights but have less enforcement and bargaining power.
Takeaway: The amendment did not abandon benefit sharing for oral knowledge; it made the remaining promise harder to enforce.
Why do existing records not protect the knowledge?
Every Biodiversity Management Committee must maintain a People’s Biodiversity Register recording local resources and associated knowledge. Legal researcher and practicing advocate Aaditya Bajpai, author of the underlying analysis, puts the point plainly: “a register is a record, not a right.”
Registering knowledge does not make it codified under Section 2(ea), because the definition points to the Drugs and Cosmetics Act’s classical texts rather than community registers. Entry therefore grants neither the benefit-sharing exemption nor the defensive protection available to codified knowledge.
India’s Traditional Knowledge Digital Library, the prior-art database that helped defeat turmeric and neem patent claims abroad, covers five codified traditions: Ayurveda, Unani, Siddha, Sowa-Rigpa and Yoga. Northeast oral knowledge appears in neither the recognised books nor the library.
A foreign applicant claiming a Mishmi remedy would meet no library entry. Communities face exposure twice: weakened benefit sharing at home and no defensive mechanism abroad. Oral transmission keeps the knowledge alive and, within the present statutory architecture, legally invisible. A neat bureaucratic trick, with large consequences.
Takeaway: The law documents oral knowledge without giving that record enforceable legal force.
What reform would close the gap?
The analysis rejects the idea that communities should force oral knowledge into a form they never kept. Instead, it proposes attaching a real benefit-sharing entitlement and a genuine defensive-protection mechanism to the People’s Biodiversity Register that the law already requires.
Such protection would operate without declaring community knowledge codified under Section 2(ea). It would also align the present regime with Divya Pharmacy’s holding that domestic users cannot appropriate community resources and knowledge without sharing benefits.
Takeaway: A register should open a route to rights, not merely record knowledge that the law discounts.
via livelaw.in (Source)
More from Amara Osei
Show full bio
Senior reporter covering people, launches and day-to-day practice in International law and legal practice at Global Law Wire.
327 articles
Also before the court
- India's Anti-Doping Act Is Now in Force — But Are Its New Criminal Penalties Workable?
- FDA Hits Caplin Steriles Plant With OAI Status After 10 Observations
- Allahabad Ruling Exposes India's Transgender Rape-Law Gap
- FDA Classifies Wanbury’s Tanuku API Plant OAI in November 2026
- India's Parliament Fails to Pass Women's Quota Expansion Bill